KIRITSY CHRISTOPHER P
Insider CIK 1261156 · HTGM Director · PVLA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise deriv | 2026-09-02 | 2026-09-04 | 313 | — | $0 | 0 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | S Sale | 2026-09-02 | 2026-09-04 | 313 | $157.00 | $49.1K | 250 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise | 2026-09-02 | 2026-09-04 | 313 | $127.20 | $39.8K | 563 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise deriv | 2026-09-02 | 2026-09-04 | 313 | — | $0 | 0 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | S Sale | 2026-09-02 | 2026-09-04 | 313 | $157.00 | $49.1K | 250 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise | 2026-09-02 | 2026-09-04 | 313 | $127.20 | $39.8K | 563 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2026-06-10 | 2026-06-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2025-06-10 | 2025-06-11 | 12,350 | — | $0 | 12,350 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2024-12-13 | 2024-12-17 | 24,700 | — | $0 | 24,700 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2024-12-02 | 2024-12-09 | 500 | — | $0 | 500 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2023-05-25 | 2023-05-30 | 10,000 | $0.85 | $8.5K | 20,000 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2022-09-15 | 2022-09-15 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2022-01-27 | 2022-01-31 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2021-06-25 | 2021-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-06-23 | 2020-06-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-06-23 | 2020-06-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-01-25 | 2020-01-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2018-09-14 | 2018-09-17 | 5,000 | $5.11 | $25.6K | 10,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-01-25 | 2018-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-04-21 | 2017-05-09 | 5,000 | — | $0 | 25,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-04-21 | 2017-05-09 | 5,000 | $1.59 | $8.0K | 5,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-01-25 | 2017-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-09-20 | 2016-09-22 | 30,000 | — | $0 | 30,000 | SEC↗ |